「VEGF」に関連した動画の一覧

	VEGF pathway: Target several targeted therapies against cancer Avastin Sutent Nexavar  Mechanism of action of VEGF (vascular endothelial growth factor) signalling pathway. Mécanisme d'action de la voie de signalisation du VEGF (facteur de croissance endothéliale vasculaire). EFP Website: www.efp-online.org. European Fellowship for Pharmacists 2010年07月14日再生回数 7815
	VEGF and EGFR pathways in detail: Target for new therapies against cancer  Mechanism of action of VEGF (vascular endothelial growth factor) and EGFR (epidermal growth factor receptor) signalling pathways. Mécanisme d'action des voies de signalisation du VEGF et de l'EGFR. EFP Website: www.efp-online.org. European Fellowship for Pharmacists 2010年07月14日再生回数 27790
	VEGF & Cancer development  CGI representation of tumor growth, VEGF and a mechanism for blocking. 2008年11月13日再生回数 13230
	Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of Macular Edema.mpg  In thisvideo Dr Suresh K Pandey & Dr Vidushi Sharma, Eye Surgeons of SuVi Eye Institute, Kota, Rajasthan, India (www.suvieye.com) share pearls for Intravitreal Injection on Anti-VEGF Bevacizumab (Avastin) in a case of diabetic Macular Edema. Intravitreal injection of Anti-VEGF (Avastin) has shown beneficial in cases of refractive macular edema (diabetes, CRVO), SRNVM (wet ARMD), etc. Refractory macular edema, or swelling around the macula, is edema that affects vision but does not respond adequately to the usual treatment methods. It can occur with conditions such as central retinal vein occlusion and diabetic retinopathy. Without effective treatment, vision loss could progress and become permanent. Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50 years of age. It is caused by the breakdown of the central portion of the retina (the nerve layer part of your eye that works like the film in a camera to pick up the picture) called the macula. The macula is responsible for the fine central vision in the eye that is needed for driving a car, reading fine print, recognizing faces, etc. There are two types of macular degeneration: dry and wet. In the wet form of AMD, abnormal blood vessels grow in the back of the eye. Sometimes these vessels leak blood or fluid that causes blurred or distorted vision. Without treatment, vision loss may be quick and severe. There are other eye conditions that cause loss of vision due to abnormal growth of ... 2011年04月09日再生回数 7331
	Electro-Medicine : Biological Physics - Angiogenesis VEGF and Bjorn Nordenstrom BCEC  youtu.be youtu.be youtu.be youtu.be NOTE : Angiogenesis INHIBITION PLATELET FACTOR 4 Prof. Gera Neufeld New Cancer Fibrosis Treatment Lysyl-Oxidase family called LOXL2 Björn Nordenström has utilized concepts in physics, mathematics, chemistry, physiology and immunology; combined with a massive amount of experimentation; to describe a system of continuous energy circulation and circulating electrical currents in living systems. Living cells consist of ions, charged molecules, membranes and organelles, which are responsive to electrical fields and currents and sometimes even generate electrical activity. When a non-uniform electric field is generated near living cells, polar molecules will move towards the higher field intensity. When an altering current is generated the molecules stay in place, their reaction being only vibration. However, in dividing cells the altering field causes the molecules to move towards the furrow, which is the narrow place between the two daughter cells. Using this principle the scientists had a way to tell apart normal cells from dividing cells, which are normally cancerous cells. Biologically Closed Electric Circuits, Björn EW Nordenström, MD, (Nordic Medical Publications, Arsenalsgatan 4, S-1ll 47 Stockholm, Sweden), This remarkable book introduces a new physiologic concept that could solve many long-standing biologic problems. This far-reaching concept evolved from a series of ingenious experiments that began with the author's search for the ... 2011年11月08日再生回数 461
	VEGF and CNV  Vascular Endothelial Growth Factor (VEGF) and Chroidal Neovascularization (CNV). 2007年07月24日再生回数 1579
	VEGF  VEGF (Vascular Endothelial Growth Factor) is a signaling molecule that binds to receptors on blood vessels. The binding VEGF to the receptors signals the blood vessels to sprout and elongate toward the source of the VEGF. Tumors release VEGF, stimulating the development of their own blood supply thus supporting their further growth. This animation includes audio narration: please make sure your computer's volume is up so that you can hear it. Source : www.hhmi.org 2010年04月27日再生回数 553
	CRVO Treatments: What are Anti-VEGF Agents?  Basic descriptions of Anti-VEGF agents from a central retinal vein occlusion patient's perspective. CRVO Support Group: groups.google.com Outline of available CRVO videos: sites.google.com Patient to patient notes for a quick start toward understanding CRVO: sites.google.com 2008年10月21日再生回数 7059
	Dr. Chan Discusses the VEGF-Trap Agent Aflibercept  Emily Chan, MD, PhD, Assistant Professor of Medicine, Vanderbilt University Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, discusses the investigatory agent aflibercept, a vascular endothelial growth factor (VEGF)-trap agent. Aflibercept acts as a decoy receptor, which causes pro-angiogenic VEGFs to bind to its ligands rather than the correct VEGF receptors. Trapping VEGF with false receptors prevents tumor angiogenesis. Historically VEGF has proven to be an active target in colorectal cancer and is successfully inhibited at different points by other agents, such as bevacizumab. Although aflibercept is not currently an approved agent promising data was released supporting its use in metastatic colorectal cancer at the 2011 ECCO/ESMO meeting. Multiple trials are currently underway looking at disease types that have demonstrated VEGF target efficacy. 2012年01月14日再生回数 178
	Another anti-VEGF drug showing promise for diabetic macular edema  NEW YORK (Reuters Health) - In a phase 2 study of patients with diabetic macular edema (DME), intravitreal injections of the vascular endothelial growth factor inhibitor, VEGF Trap-Eye, proved superior to macular laser treatment, researchers report. For more information, please visit: www.thedoctorschannel.com 2011年06月23日再生回数 317